I-Mab Announces Multiple Presentations at the 2022 American Association for Cancer Research (AACR) Annual Meeting
SHANGHAI and GAITHERSBURG, Md., March 9, 2022 /PRNewswire/ -- I-Mab (the Company) (Nasdaq: IMAB), a clinical-stage biopharmaceutical company com...
Source: businessinsider.com